Myriad Genetics, Inc. (MYGN)

Myriad Genetics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	825.3	837.6	753.2	678.4	690.6	557
Revenue Growth (YoY)	0.21%	11.21%	11.03%	-1.77%	23.99%	-12.78%
Cost of Revenue	244.6	252.2	236.2	202	197.6	178.2
Gross Profit	580.7	585.4	517	476.4	493	378.8
Selling, General & Admin	549.3	560	567.2	514.7	537.8	500.7
Research & Development	113.5	113.4	88.7	85.4	81.9	72.9
Operating Expenses	662.8	673.4	655.9	600.1	619.7	573.6
Operating Income	-82.1	-88	-138.9	-123.7	-126.7	-194.8
Interest Expense	-6.8	-2.8	-2.9	-3.2	-6.6	-11.2
Interest & Investment Income	1.3	1.7	2.5	2.6	0.7	2
Currency Exchange Gain (Loss)	-1.1	-1.1	-3.4	-	-	-
Other Non Operating Income (Expenses)	1.8	2.2	0.5	0.6	-0.6	15.3
EBT Excluding Unusual Items	-86.9	-88	-142.2	-123.7	-133.2	-188.7
Impairment of Goodwill	-234.7	-	-	-16.9	-1.8	-90.4
Gain (Loss) on Sale of Investments	-	-	-1.5	-	-	-
Gain (Loss) on Sale of Assets	1.4	-12.4	-	-	151.6	-
Asset Writedown	-126.4	-44.4	-5.7	-	-	-8
Legal Settlements	21.3	21.3	-112.8	-	-62	-
Other Unusual Items	-	-	-	-	-11.7	3.4
Pretax Income	-425.3	-123.5	-262.2	-140.6	-57.1	-283.7
Income Tax Expense	-24.8	3.8	1.1	-28.6	-29.9	-59.9
Earnings From Continuing Operations	-400.5	-127.3	-263.3	-112	-27.2	-223.8
Minority Interest in Earnings	-	-	-	-	-	0.1
Net Income	-400.5	-127.3	-263.3	-112	-27.2	-223.7
Net Income to Common	-400.5	-127.3	-263.3	-112	-27.2	-223.7
Shares Outstanding (Basic)	92	91	83	81	78	75
Shares Outstanding (Diluted)	92	91	83	81	78	75
Shares Change (YoY)	2.77%	9.42%	2.73%	3.33%	4.31%	0.64%
EPS (Basic)	-4.36	-1.41	-3.18	-1.39	-0.35	-2.99
EPS (Diluted)	-4.36	-1.41	-3.18	-1.39	-0.35	-2.99
Free Cash Flow	-16.7	-27.7	-174.1	-151.6	0.6	-40.1
Free Cash Flow Per Share	-0.18	-0.31	-2.10	-1.88	0.01	-0.54
Gross Margin	70.36%	69.89%	68.64%	70.22%	71.39%	68.01%
Operating Margin	-9.95%	-10.51%	-18.44%	-18.23%	-18.35%	-34.97%
Profit Margin	-48.53%	-15.20%	-34.96%	-16.51%	-3.94%	-40.16%
Free Cash Flow Margin	-2.02%	-3.31%	-23.11%	-22.35%	0.09%	-7.20%
EBITDA	-26.2	-26.8	-82.7	-71	-63.9	-123.4
EBITDA Margin	-3.17%	-3.20%	-10.98%	-10.47%	-9.25%	-22.15%
D&A For EBITDA	55.9	61.2	56.2	52.7	62.8	71.4
EBIT	-82.1	-88	-138.9	-123.7	-126.7	-194.8
EBIT Margin	-9.95%	-10.51%	-18.44%	-18.23%	-18.35%	-34.97%
Revenue as Reported	-	-	-	-	690.6	557
Advertising Expenses	-	10.3	8.5	5.3	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q